152
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Gender Differences in Psychiatric Symptoms and the Social Functioning of 610 Patients with Schizophrenia in Urban China: A 10-Year Follow-Up Study

, , , , ORCID Icon, ORCID Icon, , & show all
Pages 1545-1551 | Received 09 May 2022, Accepted 21 Jul 2022, Published online: 27 Jul 2022

References

  • Huang Y, Wang YU, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–224. doi:10.1016/S2215-0366(18)30511-X
  • Tripathi A, Kar SK, Shukla R. Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies. Clin Psychopharmacol Neurosci. 2018;16(1):7–17. doi:10.9758/cpn.2018.16.1.7
  • Strassnig M, Bowie C, Pinkham AE, et al. Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia? J Psychiatr Res. 2018;104:124–129. doi:10.1016/j.jpsychires.2018.06.018
  • Carruthers SP, Van Rheenen TE, Gurvich C, et al. Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis. Neurosci Biobehav Rev. 2019;107:252–278. doi:10.1016/j.neubiorev.2019.09.006
  • Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019;18(2):146–161. doi:10.1002/wps.20624
  • Adery LH, Ichinose M, Torregrossa LJ, et al. The acceptability and feasibility of a novel virtual reality based social skills training game for schizophrenia: preliminary findings. Psychiatry Res. 2018;270:496–502. doi:10.1016/j.psychres.2018.10.014
  • Inchausti F, García-Poveda NV, Ballesteros-Prados A, et al. The effects of metacognition-oriented social skills training on psychosocial outcome in schizophrenia-spectrum disorders: a randomized controlled trial. Schizophr Bull. 2018;44(6):1235–1244. doi:10.1093/schbul/sbx168
  • Turner DT, McGlanaghy E, Cuijpers P, et al. A meta-analysis of social skills training and related interventions for psychosis. Schizophr Bull. 2018;44(3):475–491. doi:10.1093/schbul/sbx146
  • Granholm E, Holden J, Worley M. Improvement in negative symptoms and functioning in cognitive-behavioral social skills training for schizophrenia: mediation by defeatist performance attitudes and asocial beliefs. Schizophr Bull. 2018;44(3):653–661. doi:10.1093/schbul/sbx099
  • Navarra-Ventura G, Fernandez-Gonzalo S, Turon M, et al. Gender differences in social cognition: a cross-sectional pilot study of recently diagnosed patients with schizophrenia and healthy subjects. Can J Psychiatry. 2018;63(8):538–546. doi:10.1177/0706743717746661
  • Šimunović Filipčić I, Ivezić E, Jakšić N, et al. Gender differences in early onset of chronic physical multimorbidities in schizophrenia spectrum disorder: do women suffer more? Early Interv Psychiatry. 2020;14(4):418–427.
  • Seeman MV. Does gender influence outcome in schizophrenia? Psychiatr Q. 2019;90(1):173–184. doi:10.1007/s11126-018-9619-y
  • Riecher-Rössler A, Butler S, Kulkarni J. Sex and gender differences in schizophrenic psychoses - a critical review. Arch Womens Ment Health. 2018;21(6):627–648. doi:10.1007/s00737-018-0847-9
  • Brand BA, de Boer JN, Dazzan P, et al. Towards better care for women with schizophrenia-spectrum disorders. Lancet Psychiatry. 2022;9(4):330–336. doi:10.1016/S2215-0366(21)00383-7
  • Seeman MV. Women who suffer from schizophrenia: critical issues. World J Psychiatry. 2018;8(5):125–136. doi:10.5498/wjp.v8.i5.125
  • Brand BA, Haveman YRA, De Beer F, et al. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol Med. 2021;52(4):1–15.
  • González-Rodríguez A, Guàrdia A, Álvarez Pedrero A, et al. Women with schizophrenia over the life span: health promotion, treatment and outcomes. Int J Environ Res Public Health. 2020;17(15):5594. doi:10.3390/ijerph17155594
  • Li AWY, Hui CLM, Lee EHM, et al. Gender differences in correlates of cognition in first-episode psychosis. Psychiatry Res. 2019;271:412–420. doi:10.1016/j.psychres.2018.12.011
  • Thorup A, Albert N, Bertelsen M, et al. Gender differences in first-episode psychosis at 5-year follow-up–two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry. 2014;29(1):44–51. doi:10.1016/j.eurpsy.2012.11.005
  • Grossman LS, Harrow M, Rosen C, et al. Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv. 2006;57(6):844–850. doi:10.1176/ps.2006.57.6.844
  • Rotstein A, Shadmi E, Roe D, et al. Gender differences in quality of life and the course of schizophrenia: national study. BrJ Psych Open. 2022;8(2):e35. doi:10.1192/bjo.2022.3
  • Grossman LS, Harrow M, Rosen C, et al. Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery. Compr Psychiatry. 2008;49(6):523–529. doi:10.1016/j.comppsych.2008.03.004
  • Usall J, Ochoa S, Araya S, et al. Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample. Eur Psychiatry. 2003;18(6):282–284. doi:10.1016/j.eurpsy.2003.06.001
  • Yang Y, Ning X, Wang X, et al. Triglyceride/glucose index is a reliable predictor of insulin resistance in schizophrenia. Schizophr Res. 2020;223:366–367. doi:10.1016/j.schres.2020.07.005
  • Yuan X, Wang S, Shi Y, et al. Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine. Psychopharmacology. 2022;239(3):765–771. doi:10.1007/s00213-022-06067-y
  • Chiu EC, Hung TM, Huang CM, et al. Responsiveness of the personal and social performance scale in patients with schizophrenia. Psychiatry Res. 2018;260:338–342. doi:10.1016/j.psychres.2017.11.053
  • Das S, Punnoose VP, Doval N, et al. Spirituality, religiousness and coping in patients with schizophrenia: a cross sectional study in a tertiary care hospital. Psychiatry Res. 2018;265:238–243. doi:10.1016/j.psychres.2018.04.030
  • Gonzalez-Blanco L, Garcia-Portilla MP, Dal Santo F, et al. Predicting real-world functioning in outpatients with schizophrenia: role of inflammation and psychopathology. Psychiatry Res. 2019;280:112509. doi:10.1016/j.psychres.2019.112509
  • Strauss GP, Harrow M, Grossman LS, et al. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull. 2010;36(4):788–799. doi:10.1093/schbul/sbn167
  • Newman SC, Bland RC, Thompson AH. Long-term course and outcome in schizophrenia: a 34-year follow-up study in Alberta, Canada. Psychol Med. 2012;42(10):2137–2143. doi:10.1017/S0033291712000177
  • Shimomura Y, Kikuchi Y, Suzuki T, et al. Antipsychotic treatment in the maintenance phase of schizophrenia: an updated systematic review of the guidelines and algorithms. Schizophr Res. 2020;215:8–16. doi:10.1016/j.schres.2019.09.013
  • Harrow M, Jobe TH, Faull RN. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study. Psychol Med. 2014;44(14):3007–3016. doi:10.1017/S0033291714000610
  • Harrow M, Jobe TH, Tong L. Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders. Psychol Med. 2021;2021:1–11.
  • Harrow M, Jobe TH, Faull RN. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychol Med. 2012;42(10):2145–2155. doi:10.1017/S0033291712000220
  • Goff DC, Falkai P, Fleischhacker WW, et al. The long-term effects of antipsychotic medication on clinical course in schizophrenia. Am J Psychiatry. 2017;174(9):840–849. doi:10.1176/appi.ajp.2017.16091016
  • Harrow M, Jobe TH, Tong L. Long-term effectiveness of antipsychotics. Psychol Med. 2021;2021:1–5.
  • Pierre JM, Zito MF, Yang YS, et al. Antipsychotic discontinuation and recovery: chicken or egg? Psychol Med;2021. 1–2. doi:10.1017/S0033291721001872
  • Ran MS, Weng X, Chan CLW, et al. Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China. Br J Psychiatry. 2015;207(6):495–500. doi:10.1192/bjp.bp.114.157685
  • Harrow M, Jobe TH. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. J Nerv Ment Dis. 2007;195(5):406–414. doi:10.1097/01.nmd.0000253783.32338.6e
  • Galderisi S, Bucci P, Üçok A, et al. No gender differences in social outcome in patients suffering from schizophrenia. Eur Psychiatry. 2012;27(6):406–408. doi:10.1016/j.eurpsy.2011.01.011
  • Ran MS, Mao WJ, Chan CLW, et al. Gender differences in outcomes in people with schizophrenia in rural China: 14-year follow-up study. Br J Psychiatry. 2015;206(4):283–288. doi:10.1192/bjp.bp.113.139733
  • Lenior ME, Dingemans PMAJ, Linszen DH, et al. Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention. Br J Psychiatry. 2001;179(1):53–58. doi:10.1192/bjp.179.1.53
  • Chien HC, Ku CH, Lu RB, et al. Effects of social skills training on improving social skills of patients with schizophrenia. Arch Psychiatr Nurs. 2003;17(5):228–236. doi:10.1016/S0883-9417(03)00095-5